Top Story

Toxic metals increase risk for CVD, CHD

September 18, 2018
In the Journals

Aspirin fails to improve CV outcomes, raises hemorrhage risk in older adults

September 17, 2018
Among older adults, low-dose aspirin did not reduce CVD risk vs. placebo and conferred an increase in risk for major hemorrhage, according to results of the ASPREE…
In the Journals

Low-dose aspirin does not improve survival in elderly

September 17, 2018
A daily 100-mg dose of aspirin had no impact on disability-free survival among healthy elderly patients, and was linked to a higher rate of major hemorrhage, according…
FDA News

FDA approves Teva’s migraine prevention drug

September 17, 2018
The FDA approved Ajovy subcutaneous injections at doses of either 675 mg quarterly or 225 mg monthly for the prevention of migraine in adults, Teva announced. Ajovy…
More Headlines »

Strategies for Achieving LDL-C Goals to Reduce ASCVD Risk

This activity is supported by an educational grant from Amgen.

There are numerous treatment options available for the management of familial hypercholesterolemia (FH) and…
More »
GI Bookshelf

Chapter 5: Bowel Obstruction And Pseudo-Obstruction

From GI Emergencies: A Quick Reference Guide
More »
Resource Centers
Heart in Diabetes

Heart in Diabetes

Meeting News Coverage

VIDEO: Recently approved Nuplazid fills treatment gap in Parkinson’s disease

May 25, 2016
More »